Skip to main content
. 2021 Apr;24(4):539–547. doi: 10.1016/j.jval.2020.10.002

Table 2.

Characteristics of Delphi panel participants.

Round 1 (n = 62)
Round 2 (n = 48)
Number (%) Number (%)
Country of health economics work
 UK 48 (77.4) 38 (79.1)
 Other Europe 10 (16.1) 7 (14.6)
 Austra/Asia 3 (4.8) 2 (4.2)
 Other 1 (1.6) 1 (2.1)
Professional background
 Health economist 60 (96.8) 47 (97.9)
 Other 2 (3.2) 1 (2.1)
Number of HEAPs experienced
 0 4 (6.5) 4 (8.3)
 ≤5 24 (38.7) 17 (35.4)
 >5 32 (51.6) 25 (52.1)
 No answer 2 (3.2) 2 (4.2)
Main work setting
 Academia 53 (85.4) 40 (83.3)
 Industry 4 (6.5) 3 (6.3)
 Other 4 (6.5) 4 (8.3)
 No answer 1 (1.6) 1 (2.1)
Main analysis type
 Within trial analysis 25 (40.3) 21 (43.7)
 Model based on a trial 8 (12.9) 6 (12.5)
 Both 29 (46.8) 21 (43.7)
Years in health economics
 <5 11 (17.7) 7 (14.6)
 5-10 14 (22.6) 13 (27.1)
 11-20 26 (41.9) 21 (43.7)
 >20 11 (17.7) 7 (14.6)